Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT

Marker Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.73M -14.05M -29.93M -41.88M
Depreciation & Amortization
n/a n/a 3.68M 3.16M
Stock-Based Compensation
245.86K 858.27K 3.3M 5.96M
Other Working Capital
-433.63K 861.11K -1.51M 1.33M
Other Non-Cash Items
n/a -6.1M -252.69K 7.15M
Deferred Income Tax
n/a n/a n/a -7.15M
Change in Working Capital
-424.87K 2.85M -5.81M 5.47M
Operating Cash Flow
-10.91M -16.44M -26.97M -27.28M
Capital Expenditures
n/a n/a -4.95M -3.13M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 18.66M -4.95M -1.56M
Investing Cash Flow
n/a 18.66M -4.95M -3.13M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
62.16K 90.48K n/a 3.09K
Financial Cash Flow
14.99M 1.11M 202.13K 52.56M
Net Cash Flow
4.08M 3.33M -31.72M 22.14M
Free Cash Flow
-10.91M -16.44M -31.92M -30.41M